Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 132

Similar articles for PubMed (Select 21392102)

1.

Urinary tract infections owing to ESBL-producing bacteria: microorganisms change--clinical pattern does not.

Özçakar ZB, Yalçınkaya F, Kavaz A, Kadıoğlu G, Elhan AH, Aysev D, Güriz H, Ekim M.

Acta Paediatr. 2011 Aug;100(8):e61-4. doi: 10.1111/j.1651-2227.2011.02262.x. Epub 2011 Mar 30.

PMID:
21392102
2.

The Clinical Efficacy and Safety of Ertapenem for the Treatment of Complicated Urinary Tract Infections Caused by ESBL-Producing Bacteria in Children.

Karaaslan A, Kadayifci EK, Atici S, Akkoc G, Yakut N, Öcal Demir S, Soysal A, Bakir M.

Int J Nephrol. 2015;2015:595840. doi: 10.1155/2015/595840. Epub 2015 May 27.

3.

Epidemiology and characteristics of urinary tract infections in children and adolescents.

Hanna-Wakim RH, Ghanem ST, El Helou MW, Khafaja SA, Shaker RA, Hassan SA, Saad RK, Hedari CP, Khinkarly RW, Hajar FM, Bakhash M, El Karah D, Akel IS, Rajab MA, Khoury M, Dbaibo GS.

Front Cell Infect Microbiol. 2015 May 26;5:45. doi: 10.3389/fcimb.2015.00045. eCollection 2015.

4.

ESBL-producing enterobacteriaceae-related urinary tract infections in kidney transplant recipients: incidence and risk factors for recurrence.

Pilmis B, Scemla A, Join-Lambert O, Mamzer MF, Lortholary O, Legendre C, Zahar JR.

Infect Dis (Lond). 2015 May 29:1-5. [Epub ahead of print]

PMID:
26024285
5.

A comparison of the clinical characteristics of elderly and non-elderly women with community-onset, non-obstructive acute pyelonephritis.

Chang UI, Kim HW, Noh YS, Wie SH.

Korean J Intern Med. 2015 May;30(3):372-83. doi: 10.3904/kjim.2015.30.3.372. Epub 2015 Apr 29.

6.

[Detection of unusual uropathogens during a period of three years in a regional hospital].

Gómez-Camarasa C, Liébana-Martos C, Navarro-Marí JM, Gutiérrez-Fernández J.

Rev Esp Quimioter. 2015 Apr;28(2):86-91. Spanish.

7.
8.

Comparison of community-onset healthcare-associated and hospital-acquired urinary infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and antimicrobial activities.

Saltoglu N, Karali R, Yemisen M, Ozaras R, Balkan II, Mete B, Tabak F, Mert A, Hondur N, Ozturk R.

Int J Clin Pract. 2015 Jul;69(7):766-70. doi: 10.1111/ijcp.12608. Epub 2015 Feb 16.

PMID:
25683907
9.

Impact of antibiotic resistance on the development of recurrent and relapsing symptomatic urinary tract infection in kidney recipients.

Bodro M, Sanclemente G, Lipperheide I, Allali M, Marco F, Bosch J, Cofan F, Ricart MJ, Esforzado N, Oppenheimer F, Moreno A, Cervera C.

Am J Transplant. 2015 Apr;15(4):1021-7. doi: 10.1111/ajt.13075. Epub 2015 Feb 12.

PMID:
25676738
10.

[Management of urinary tract infections in children. Evaluation of clinical practice].

Bontemps S, Lagrée M, Dessein R, Maftei A, Martinot A, Dubos F.

Arch Pediatr. 2015 Jan;22(1):24-31. doi: 10.1016/j.arcped.2014.10.005. Epub 2014 Nov 1. French.

PMID:
25482995
11.

Infezioni delle vie urinarie: appropriatezza in antibioticoterapia.

Bassetti M, Carnelutti A.

Urologia. 2014 Dec 1;0(0):26-30. doi: 10.5301/uro.5000081. [Epub ahead of print]

PMID:
25451876
12.

Klebsiella spp urinary tract infections during first year after renal transplantation.

Gołębiewska J, Tarasewicz A, Dębska-Ślizień A, Rutkowski B.

Transplant Proc. 2014 Oct;46(8):2748-51. doi: 10.1016/j.transproceed.2014.09.074.

PMID:
25380908
13.

Effect of ceftriaxone on the outcome of murine pyelonephritis caused by extended-spectrum-β-lactamase-producing Escherichia coli.

Tratselas A, Simitsopoulou M, Giannakopoulou A, Dori I, Saoulidis S, Kollios K, Papaioannidou P, Pournaras S, Roilides E.

Antimicrob Agents Chemother. 2014 Dec;58(12):7102-11. doi: 10.1128/AAC.03974-14. Epub 2014 Sep 15.

14.

Clinical and bacteriological efficacy of amikacin in the treatment of lower urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumoniae.

Ipekci T, Seyman D, Berk H, Celik O.

J Infect Chemother. 2014 Dec;20(12):762-7. doi: 10.1016/j.jiac.2014.08.007. Epub 2014 Aug 30.

PMID:
25179392
15.

Extended-spectrum β-lactamase-producing bacteria causing community-acquired urinary tract infections in children.

Megged O.

Pediatr Nephrol. 2014 Sep;29(9):1583-7. doi: 10.1007/s00467-014-2810-y. Epub 2014 Apr 5.

PMID:
24705795
16.

Changing epidemiology of infections due to extended spectrum beta-lactamase producing bacteria.

Kassakian SZ, Mermel LA.

Antimicrob Resist Infect Control. 2014 Mar 25;3(1):9. doi: 10.1186/2047-2994-3-9.

17.

Extended-spectrum-beta-lactamase producing bacteria related urinary tract infection in renal transplant recipients and effect on allograft function.

Ramadas P, Rajendran PP, Krishnan P, Alex A, Siskind E, Kadiyala A, Jayaschandran V, Basu A, Bhaskaran M, Molmenti EP.

PLoS One. 2014 Mar 17;9(3):e91289. doi: 10.1371/journal.pone.0091289. eCollection 2014.

18.

Urinary tract infections caused by extended-spectrum betalactamase-producing bacteria in children: a matched casecontrol study.

Dotis J, Printza N, Marneri A, Gidaris D, Papachristou F.

Turk J Pediatr. 2013 Nov-Dec;55(6):571-4.

19.

Outcome of Antimicrobial Therapy of Pediatric Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae.

Lee B, Kang SY, Kang HM, Yang NR, Kang HG, Ha IS, Cheong HI, Lee HJ, Choi EH.

Infect Chemother. 2013 Dec;45(4):415-21. doi: 10.3947/ic.2013.45.4.415. Epub 2013 Dec 27.

20.

Impact of extended-spectrum β-lactamase-producing organisms on clinical and economic outcomes in patients with urinary tract infection.

MacVane SH, Tuttle LO, Nicolau DP.

J Hosp Med. 2014 Apr;9(4):232-8. doi: 10.1002/jhm.2157. Epub 2014 Jan 24.

PMID:
24464783
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk